CompaniesPaloma Pharmaceuticals

Paloma Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedTerminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

13

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
Today
NCT01033721
Hover over trial bars to see details

Recent Trials

NCT01033721Lead Sponsor
Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration
PHASE1Completed
13 participants
Started: Jun 30, 2010 · Completed: Dec 31, 2011
Funding History (2)
D
Sep 10, 2010
Filing
D
Sep 2, 2009
Filing
Related Companies
Stratus Media
acquired